Background: Epithelial to mesenchymal transition (EMT) is considered to be important for cancer invasion and metastasis. Tumour hypoxia, in addition to Transforming Growth Factor-β (TGF-β) and Notch, amongst others, have been suggested to be involved in EMT. We therefore investigated if hypoxia, TGF-β1 and the Notch ligand Jagged-1 alone induced morphological changes with corresponding EMT signatures in different epithelial breast cancer cell lines in vitro. Furthermore, we also studied whether or not TGF-β1, or Jagged-1 in combination with hypoxia added any effect on EMT. Methods: The cells were exposed to normoxia or hypoxia alone or in combination with TGF-β1 or Jagged-1. Morphological responses to treatment were investigated by light microscopy, and changes in markers for EMT and hypoxia were evaluated by western blot analysis and immunofluorescence studies. Results: One of the four cell lines (MCF7) became elongated and highly multipolar, indicative of EMT, following hypoxia, TGF-β1 and Jagged-1 treatment per se with the most distinct morphological shift seen with Jagged-1 treatment in combination with hypoxia. Also, when regarding hypoxia, MCF7 cells showed the greatest change in EMT-markers of the four cell lines tested, but these changes were not consistent with a typical EMT pattern. The morphology of BT474 cells was not altered following Jagged-1 treatment, however, Jagged-1 increased E-cadherin levels. Morphology was changed following TGF-β1 treatment of BT474 cells, but it did not affect E-cadherin levels. Neither Jagged-1 nor TGF-β1 altered the levels of Vimentin in the BT474 cell line. The E-cadherin responses to hypoxia varied with end-point in both MCF7 and BT474 cells, and in most cases were not consistent with EMT. Conclusion: Our results using four different breast cancer cell lines in vitro do not provide evidence that EMT is induced by hypoxia alone or in combination with TGF-β1 or the Notch ligand Jagged-1. The inconsistency in morphological appearance and EMT-markers, as well as the time dependent variation in E-cadherin responses could not support EMT. Importantly, there was not one single common response pattern to the stimuli used, suggesting that cell lines with different hormone statuses display individual traits that respond differently to the stimuli applied. Thus, based on the present results, common statements that single factors by themselves can induce EMT seem questionable.
Introduction
Hypoxia is a common feature in most solid tumours. As the tumour grows, it rapidly outgrows its blood supply, and hypoxic areas develop beyond the diffusion range of tissue oxygen. Despite the formation of new vessels, tumour angiogenesis often results in poorly functioning blood vessels that have a reduced ability to provide well-oxygenated blood [1] . In addition, tumours by themselves can result in anaemia through blood loss, enhanced destruction of red blood cells and lowered production of functional red blood cells, as well as the effect of using therapeutic agents [2] . Together this results in derangement of oxygen delivery. The hypoxic areas tend to be heterogeneously distributed throughout the tumour, and areas can be subjected to cycles of deoxygenation and reoxygenation [3] .
Hypoxia is believed to have a fundamental role in solid tumours. The low oxygen levels can create an environment which will kill some of the tumour cells, however, this will also mediate a "survival of the fittest" scenario where the cells that can either adapt to harsh http://dx.doi.org/10.1016/j.yexcr.2017.07.021conditions or migrate towards more oxygenated areas survive, hence hypoxia is associated with a worsened prognosis [4] . Hypoxia in tumours is known to be a challenge with respect to drug delivery and therapeutics, but it has also proved to be an important factor in cancer development and progression by influencing angiogenesis, apoptosis, cell proliferation and metastasis [1] . Hypoxia activates many signalling pathways and gene regulatory mechanisms, and a key mediator in the responses is Hypoxia Inducible Factor-1 (HIF-1) [5, 6] .
Hypoxia, in addition to Transforming Growth Factor-β (TGF-β) and Notch, has also been suggested to be involved in EpithelialMesenchymal Transition (EMT) in cancer cells [4, [7] [8] [9] . There is evidence that EMT is a crucial factor in carcinogenesis, more specifically in metastasis, invasion and the acquisition of therapeutic resistance [10, 11] . EMT is defined by epithelial cells losing their stable cobble-stone appearance and transforming into cells with an increased invasive and migratory capacity. Contrary to epithelial cells, mesenchymal cells have an elongated appearance, display reduced cell-cell contact and have a less rigid cytoskeleton [11] . Cells with mesenchymal properties can be identified by specific markers such as E-cadherin, NCadherin, Snail, Twist and Vimentin, where expression of SNAIL, Twist, N-Cadherin and Vimentin increases, while that of E-cadherin decreases [9, 12] . Lowered E-cadherin expression contributes to a reduction in cell-cell adhesion causing destabilisation of the epithelial structure [9] .
Although a large number of molecules have been identified to play a role in the EMT process, little is known about what initially triggers this event in cancer. It has been suggested that the induction of EMT is dependent on multiple stimuli such as tumour-stroma interactions, growth factor signalling and hypoxia [13] . Furthermore, EMT has been suggested to play a part in many tumour models in animals, however, it has proved to be challenging to obtain direct evidence of this in patients, where it has been proposed that current markers of EMT are not dependable enough [7, 14] .
The specific aim of the present study was to investigate if hypoxia, TGF-β1 and the Notch ligand Jagged-1 alone could induce morphological changes with corresponding EMT signatures in different epithelial breast cancer cell lines in vitro. Furthermore, we also investigated whether TGF-β1, or Jagged-1 in combination with hypoxia had an added effect on EMT.
Materials and methods

Tumour cell lines
In the present study we used the following human breast cancer cell lines: MCF7, BT474, BT549 and HCC1569 (Table 1 ). All cell lines were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA).
Cell culture
All cell lines were grown in RPMI-1640 medium supplemented with 10% Foetal Bovine Serum, 100 units/ml penicillin, 100 μg/ml streptomycin and 2% L-glutamine (all from Sigma-Aldrich, St Louis, MO, USA) at 37°C in a humidified incubator with 5% CO 2 and 95% air.
All cells, except those treated with Jagged-1, were first seeded and left over night to attach in standard medium and normoxic conditions. Thereafter, the medium was changed before incubation under either mild hypoxic (2% O 2 ) (Sanyo, MCO-5M) or normoxic (21% O 2 ) (Sanyo, MCO-18AIC) conditions. For Jagged-1 treatment, the wells were coated with Jagged-1 prior to seeding the cells.
In the first part of the study, where we investigated the effect of hypoxia alone, lysates for western blot were prepared after 96 h incubation. Morphological changes in response to hypoxia were studied in cells seeded on 6-well plates. Images were acquired when the cells were put in the incubator (0 h), and after 24 and 48 h. HIF-I immunofluorescence staining was performed after the cells had grown on coverslips for 24 or 96 h.
The TGF-β1 treated cells were supplied with 5 ng/ml Recombinant Human TGF-β1 (240-B-002/CF, R & D Systems Inc, Minneapolis, MN, USA) or control reconstitution solution (4 mM HCl with 0.1% BSA) for TGF-β1. After 48 and 72 h of treatment, cell morphology was evaluated and after 72 h lysates for western blot analysis were prepared. Experiments were terminated at 72 h, since beyond this point the cells were too confluent to allow further morphological evaluation.
The Notch ligand Jagged-1(human):Fc (human) (AG-40A-0081, Adipogen, Liestal, Switzerland) or control Fc (human) IgG1 (AG-35B-0007, Adipogen, Liestal, Switzerland) was directly coated at 1 µg/ml in 2800 µl PBS in the wells of a 6-well plate and left overnight (20 h) at 4°C to attach. The wells were then gently washed with PBS, cells were seeded and the plates placed in the incubators. Cell morphology was evaluated after 48 h, 72 h, 96 h and 120 h, and to ensure enough protein, lysates for western blot analysis were prepared at 120 h.
Morphology
A separate set of experiments to those used for western blot were used to study any morphological changes that occurred in response to treatment, a Primo Vert Monitor Microscope (Carl Zeiss Microscopy GmbH, Gottingen, Germany) was used.
Immunofluorescence
Coverslips were placed in each well of a 12-well plate and sterilised in a microwave oven for 2 min. For fixation, the cells were washed twice with ice cold PBS, and fixed using 4% paraformaldehyde in PBS for 10 min at room temperature. Furthermore, the cells were permeabilised in 0.5% Triton X-100 in PBS for 4 min, followed by three washes with PBS. The coverslips were then removed from the plate and incubated in blocking buffer (0.5% BSA in PBS, sterile filtered) for 15 min at room temperature, followed by incubation with primary antibody diluted in blocking buffer (1:100) for 45 min at 37°C. Thereafter, the coverslips were washed 3 × 3 min at room temperature before the secondary antibody diluted in blocking buffer (1:200) was added for 45 min at 37°C. Finally, the coverslips were washed 3 × 3 min in PBS before they were mounted on glass slides using Vectashield with DAPI (Vector Laboratories, Burlingame, CA, USA). Images were acquired using a Zeiss confocal microscope, Zeiss LSM 510 Meta (Carl Zeiss MicroImaging GmbH, Jena, Germany). Acquired images were 63x.
Western blot
When harvesting cells for western blot analysis, cells were kept on ice at all times. The cells were washed twice with ice cold PBS before RIPA buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100 and 1 tablet protease inhibitor cocktail, Complete Mini, EDTA-free (Roche, Mannheim, Germany) per 10 ml buffer solution was added. Using a cell scraper, the cell suspension was collected in Eppendorf tubes and incubated on ice for 10 min. The Table 1 The receptor status, cell line subtype and tumour type of the four cell lines investigated [15] . 
Cell line ER PR HER2 Cell line subtype
Antibodies
Rabbit polyclonal antibody to N-Cadherin (ab76057, Abcam, Cambridge, UK), Twist (ab49254, Abcam, Cambridge, UK), SNAIL + SLUG (ab63371, Abcam, Cambridge, UK), Vimentin (ab58462, Abcam, Cambridge, UK), E-cadherin (20874-1-AP, Proteintech group, Chicago, IL, USA) and HIF2-α (ab199, Abcam, Cambridge, UK), and mouse anti-human HIF1-α (610959, BD Transduction Laboratories, San Jose, CA, USA) were used as primary antibodies. Anti-β-Actin antibody (ab8227, Abcam, Cambridge, UK) was used as a loading control. Goat polyclonal secondary antibody to Rabbit IgG (HRP) (ab97051, Abcam, Cambridge, UK) and Goat anti-mouse IgG-HRP (sc-2055, Santa Cruz Biotechnology, Inc, Dallas, TX, USA) were used as secondary antibodies for western blot analysis, and Goat Anti-Rabbit Ig, Human ads-FITC (4010-02, Southern Biotech, AL, USA) for immunofluorescence. 
Statistical analysis
Intensities of western blot bands were measured with Image Lab, Version 5.2.1 (Bio-Rad Laboratories Inc, Hercules, CA, USA), and intensities were corrected by comparison to the loading control β-actin. For statistical analysis, Graph Pad Prism 6 (GraphPad Software, Inc., La Jolla, CA., USA) was used. Data are presented as means ± standard deviation. Groups were compared by 2-way ANOVA, using Bonferroni correction for multiple comparisons. p < 0.05 being recognised as statistically significant. n=3 biological replications.
Results
Response to hypoxia per se
To study the specific effect of hypoxia, we first investigated the morphology of the cell lines in question. Furthermore, proteins known to be involved during EMT were studied by western blot and immunofluorescence.
MCF7 cells (Fig. 1A) showed a distinct change in morphology after 48 h of hypoxia (2% O 2 ). These cells had a mesenchymal appearance, where they became elongated and highly multipolar. A few of the MCF7 cells displayed these properties already before exposure to hypoxia, however, these changes became more prominent after 48 h of hypoxia. The morphology of BT474 (Fig. 1B) , BT549 (Fig. 1C) and HCC1569 (Fig. 1D ) cells was not altered after 48 h of hypoxia.
HIF1-α
In order to evaluate hypoxic stimulation, protein levels of HIF-1α were evaluated by western blot analysis for all cell lines (Fig. 2) . The BT474 and BT549 cells both showed a distinct up-regulation of HIF-1α after 96 h in 2% oxygen. HCC1569 did not show this distinct response to hypoxia, and MCF7 showed a clear down-regulation of HIF-1α after 96 h under hypoxic conditions. To evaluate whether HIF-2α with time had taken over for HIF-1α in the MCF7 cells, these cells were plated and fluorescently labelled with HIF-2α (Fig. 3) . It was clear that HIF1-α was prevalent during the first 24 h of hypoxia, however, after 96 h of hypoxia, HIF-1α was no longer prominent while HIF-2α was now evident.
EMT
Western blot (Fig. 2) revealed disparate EMT profiles between the four different cell lines when labelling with the classical EMT markers Fig. 2 . Western Blot of lysates from four breast cancer cell lines for selected EMT markers under normoxic and hypoxic conditions. MCF7 cells demonstrated a distinct decrease in the epithelial marker E-cadherin, with a concomitant decrease in the mesenchymal markers. BT474 and HCC1569 cells did not appear to undergo EMT after 96 h of hypoxia. BT549 cells exhibited a slight decrease in E-cadherin after 96 h of hypoxia, however, the markers of the mesenchymal phenotype did not change in response to the hypoxic environment. 
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E-cadherin, N-cadherin, Twist, Snail and Vimentin. MCF7 cells had a distinct decrease in the epithelial marker E-cadherin after hypoxia, but showed an unexpected concomitant decrease in the mesenchymal markers after 96 h of hypoxia. BT549 cells displayed a slight decrease of E-cadherin, however, the markers of the mesenchymal phenotype, N-cadherin, Twist, Snail and Vimentin did not change in response to the hypoxic environment. BT474 and HCC1569 cells did not appear to undergo EMT.
TGF-β1 and the Notch ligand Jagged-1
We also studied the effect of TGF-β1 and Jagged-1 per se, or in combination with hypoxia, on their possible contribution to the induction of EMT. Thus, MCF7 and BT474 cells were treated with either TGF-β1 or Jagged-1 under both normoxic and hypoxic conditions, and the effect was investigated morphologically and by western blot analysis.
Response to TGF-β1 per se or in combination with hypoxia -72 h
TGF-β1 contributed to the initiation of altered morphology towards a more mesenchymal phenotype in the MCF7 cells (Fig. 4) . However, TGF-β1 did not alter the expression of E-cadherin in these cells (Fig. 5) , only hypoxic treatment promoted an increase in E-cadherin (p=0.03). TGF-β1 had a suppressive effect on Vimentin expression (p=0.005). Finally, hypoxia did not potentiate the effect of TGF-β1.
BT474 cells showed a slight change in morphology after TGF-β1 treatment, with single spindle-shaped cells escaping its colonies (Fig. 4) . The morphologic response to TGF-β1 treatment was not reflected in the levels of E-cadherin or Vimentin. E-cadherin was increased in the hypoxic conditions (p=0.006), and Vimentin did not display any statistically significant change (Fig. 6) . No potentiating effect of hypoxia was seen on TGF-β1 in BT474 cells.
Response to the Notch ligand Jagged-1 per se or in combination with hypoxia -120 h
Treatment with Jagged-1 induced a profound effect on morphology in MCF7 cells (Fig. 4) . Furthermore, the combination of Jagged-1 and hypoxia evoked an even more striking change in morphology. It was clear from the development from 48 h onwards and up to 120 h that the MCF7 cells treated with Jagged-1 under hypoxic conditions underwent a marked change in EMT-like morphology compared to the cells grown in normoxic conditions (Fig. 7) .
Western blot analysis of the Jagged-1 treated MCF7-cells showed an increase in E-cadherin after 120 h (Fig. 8) , both after hypoxia (p=0.01) and after treatment with Jagged-1 alone (p=0.0004). The combined treatment also displayed an interacting effect on E-cadherin (p=0.003). Vimentin expression was weak in all four groups, and could therefore not be quantified.
The BT474 cells did not show any distinct change in morphology after hypoxia or Jagged-1 treatment (Fig. 4) . However, the expression of E-cadherin after both hypoxia (p < 0.0001) and Jagged-1 treatment (p < 0.0001) increased substantially, and an interaction between hypoxia and Jagged-1 treatment (p=0.003) was also seen (Fig. 9) . Vimentin, on the other hand, did not display any statistically significant change (Fig. 9 ).
Discussion
Hypoxia is a common trait for most tumours and is associated with tumour invasion and metastasis [1, 4, 5] . Hypoxia, as well as TGF-β and Notch, have been suggested to induce EMT, which in turn transforms the cells to become invasive and metastatic [1, 7, 9] .
The present study using four different subtypes of breast cancer cell lines investigated in vitro demonstrated that hypoxia, TGF-β1 and the Notch ligand Jagged-1 per se, or hypoxia in combination with TGF-β1 or Jagged-1, did not trigger EMT when defined by classical EMT markers. Fig. 4 . Morphology of MCF7 and BT474 cells after treatment with TGFβ and Jagged-1, with and without hypoxia. BT474 cells showed a change in morphology after TGF-β1 treatment. TGF-β1 treatment also contributed to the initiation of altered morphology towards a more mesenchymal-looking phenotype in the MCF7-cells. The MCF7-cells showed a profound effect of the Jagged-1 treatment on cell morphology, with the combination of Jagged-1 and hypoxia being the most potent combination. However, the effect of Jagged-1 was not as pronounced on the morphology of the BT474-cells.
Our findings did not show that hypoxia alone induced EMT, which is contrary to results from another in vitro study on four different cancer cell lines [15] . These authors, however, did suggest that other mechanisms could play a contributory part in the induction of EMT. Hypoxia has also been demonstrated to partially induce EMT in two non-small-cell lung cancer cell lines [16] .
In the first part of our study where the isolated effect of hypoxia was studied, only MCF7 cells responded to hypoxia with a change towards a more spindle-shaped and multipolar morphology indicating EMT. Nonetheless, the EMT markers did not follow the pattern we had expected [9, 12] , since E-cadherin was decreased after 96 h of hypoxia, despite a down-regulation of N-cadherin, Twist, Snail and Vimentin, suggesting an EMT marker-independent mechanism of collective-toamoeboid transition [17] . After 72 h and 120 h of hypoxia E-cadherin was increased in the MCF7 cell line. BT474 cells also displayed differing patterns of E-cadherin expression in response to hypoxia depending on end-points of the experiment. E-cadherin was upregulated by hypoxic conditions at 72 and 120 h, while it was unchanged at 96 h. Contrary to our findings, an earlier study reported Ecadherin to be reduced in BT474 cells following hypoxic exposure (1% Fig. 5 . Western Blot analysis of lysates from MCF7-cells treated with TGF-β1 and hypoxia for 72 h. TGF-β1 did not have an effect on the expression of E-cadherin in these cells. Hypoxic conditions promoted an increase in E-cadherin (* p=0.0253 hypoxia (H) versus normoxia (N)). TGF-β1 had a decreasing effect on Vimentin expression (# p=0.0035 TGF-β1 versus controls). Hypoxia, however did not alter the expression. Fig. 6 . Western Blot analysis of lysates from BT474-cells treated with TGF-β1 and hypoxia for 72 h. E-cadherin was increased by hypoxia (* p=0.0064 hypoxia (H) versus normoxia (N)), while TGF-β1 did not alter the levels of E-cadherin in BT474-cells. Vimentin did not display any statistically significant change in protein level.
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O 2 ) [18] . In another study where the effect of hypoxia on MCF7 cells was followed for a period of one week, it was shown that the levels of Ecadherin changed over time during exposure to 1% O 2 [19] . This is in agreement with our findings that the response of E-cadherin to hypoxia appears to fluctuate. Surprisingly, our study showed that MCF7 cells had a higher level of HIF-1α under normoxic compared to hypoxic conditions. However, we demonstrated that HIF-2α had taken over. Notably, it has been reported that dysfunctional tumour suppressor genes as well as oncogenic signalling can cause raised HIF under normoxic conditions [4] . This might explain the high levels of HIF-1α under normoxic conditions observed in the MCF7 cells. Neither did HCC1569 cells respond with a change in HIF-1α after 96 h of hypoxic treatment. We observed that HCC1569 is a very slow growing cell line, and we therefore hypothesise that a lower metabolism requires less oxygen, and perhaps needs longer time for oxygen to be a limiting factor.
TGF-β plays a double role when it comes to cancer [7, 20] . In the early stages of cancer TGF-β functions as a tumour suppressor, and in the later stages it has been shown to drive tumour progression by inducing EMT causing a more invasive and metastatic phenotype, by acting on the immune system, and by initiation of angiogenesis. TGF-β has also been proposed to be able to interact with hypoxia to cause EMT [4] .
In our study, treatment with TGF-β1 appeared to induce a slight change towards a more mesenchymal-like phenotype in both MCF7 and BT474 cells. MCF7 cells became more spindle-shaped and multi- 8 . Western Blot of lysates from MCF7-cells treated with Jagged-1 and hypoxia for 120 h. Jagged-1 treated MCF7-cells showed an increase in E-cadherin level, both after hypoxia (* p=0.0136 hypoxia (H) versus normoxia (N)) and after treatment with Jagged-1 alone (# p=0.0004 Jagged-1 versus controls). Hypoxic treatment and Jagged-1 treatment also demonstrated an interacting effect on E-cadherin (p=0.0032). Vimentin expression was too weak to perform any statistics on the western blot. polar, whilst BT474 cells developed more single cells migrating away from the colonies compared to the controls, corresponding to a more invasive phenotype. Despite observing a change in morphology, western blots only showed that TGF-β1 affected Vimentin levels in the MCF7 cell line, but not the levels of E-cadherin in either MCF7 or BT474 cells. Vimentin was also down-regulated by TGF-β1 in MCF7 cells, contrary to classical signs of EMT [11] .
In the study by Park et al. [19] , Estradiol, TGF-β1 and hypoxia were all found to have an effect on the development of breast cancer stem cells in MCF7 in vitro at 48 h, 72 h, 96 h and one week of treatment [19] . The isolated effect of TGF-β1 in their study confirms our findings that TGF-β1 does not alter E-cadherin levels in MCF7 cells. A different in vitro study investigated the isolated effect of TGF-β1 on EMT using a panel of cell lines [21] . This study did not reveal any indications of EMT in MCF7 cells after 48 h of TGF-β1 treatment, which is in line with our findings [21] . However, several earlier studies have shown that TGF-β can induce EMT in the MCF7 cell line [22] [23] [24] . As already mentioned, TGF-β plays a double role when it comes to cancer [7, 20] . Since dosage and timing, as well as cell line passage number will probably be of relevance, this makes comparison and conclusions difficult. The effect of TGF-β on development of EMT in BT474 cells is, to our knowledge, not described in the literature. Our findings did not support that EMT induction is caused by either hypoxia, TGF-β1 or Jagged-1 in this cell line.
The Notch signalling pathway [9, 25] , which is activated by five different Notch ligands, among them Jagged-1 [26] , is involved in cell proliferation, survival, apoptosis and differentiation in many organs, and has been indicated to play a role in EMT in cancerous cells [9, 27] . It has been reported that activation of the Notch-1 signalling pathway results in an EMT phenotype of the cancerous cells, and that Notchsignalling is required for converting the hypoxic stimulus into EMT [4, 27, 28] . A different study demonstrated that Notch is needed for both proliferation to occur under normoxic conditions, as well as for EMT to be initiated under hypoxic conditions [12] . Blocking of the Notch signalling pathway has been suggested as a potential novel therapy [29] . In addition, in clinical samples, the combination of highly expressed Notch1 and Jagged-1 seems to correlate with aggressive breast tumour behaviour and poor patient outcome [30] . A number of studies have found that Notch signalling can be involved in induction of EMT in MCF7 cells [12, 31, 32] . The effect of Notch signalling on development of EMT in the BT474 cell line is, to the best of our knowledge, not described previously.
In our study, Jagged-1 treatment did have an effect on MCF7 cell morphology, with the greatest change being observed in combination with hypoxia. Surprisingly these morphological changes in MCF7 cells were, accompanied by an increase in the levels of E-cadherin, which was induced by both hypoxia and Jagged-1 treatment. Furthermore, an interaction between the two treatments was also found. However, Vimentin was significantly increased by Jagged-1 in the MCF7 cell line, and this is more in line with what one would expect with respect to the observed morphological changes [9, 12, 33] . BT474 cells did not show altered morphology when subjected to Jagged-1 treatment, however, Ecadherin levels increased substantially as a result of the treatment. Notably, hypoxia had a potentiating effect on Jagged-1 treatment in the BT474 cell line, resulting in a 7-fold increase of E-cadherin compared to the control when treated simultaneously with both hypoxia and Jagged-1.
There is evidence towards E-cadherin having a more complex role in cancer progression than what was first expected [34, 35] . The loss of E-cadherin has been viewed to be a necessary feature for cells to be able to break free from the primary tumour, however, it appears that Ecadherin also can have an oncogenic function. Highly metastatic cell lines have been associated with strong E-cadherin expression, and the presence of E-cadherin has also been reported to correlate with poor patient outcome in some prostate and breast cancer patients [34, 36, 37] . This could possibly explain the varying E-cadherin responses we have seen in our studies.
In conclusion, our results from experiments using four different breast cancer cell lines in vitro, do not provide evidence that EMT is induced by hypoxia alone or in combination with TGF-β1 or the Notch ligand Jagged-1. The inconsistency in morphological appearance and EMT-markers, as well as the end-point dependent variation in E- Fig. 9 . Western Blot of lysates from BT474-cells treated with Jagged-1 and hypoxia for 120 h. Expression of E-cadherin increased significantly after both hypoxia (* p < 0.0001 hypoxia (H) versus normoxia (N)) and Jagged-1 treatment (# p < 0.0001 Jagged-1 versus controls). An interaction between hypoxia and Jagged-1 treatment was also observed (p=0.0032). Vimentin did not display any statistically significant change following neither hypoxia nor Jagged-1 treatment.
cadherin responses does not support EMT. Importantly, there was not one single common response pattern to the stimuli used, suggesting that cell lines with different hormone statuses display individual traits that respond differently to the stimuli applied. Thus, based on the present results, common statements that single factors by themselves can induce EMT seem questionable.
